Mitigate Rising Costs and Manage Patient Outcomes

Antimicrobial Resistance – AMR – is recognized by the CDC and WHO as one of the greatest threats to public health worldwide1, and having fast, actionable data to accurately diagnose patients is paramount. HealthTrackRx provides proprietary solutions to AMR, including our patient-specific antibiogram, which removes guesswork by detecting antibiotic resistance genes, helping patients receive an antibiotic that works – the first time. Our partnership with you produces increasingly positive patient outcomes while mitigating rising healthcare costs.

Antimicrobial Resistance:

A Global Crisis

Antibiotic Resistance occurs when bacteria become resistant to the antibiotics used to treat the infections they cause.1

Antimicrobial Resistance and HealthTrackRx

Antimicrobial resistance ​(AMR) is ​a global public health crisis, making empiric treatment ​options for patients difficult. Inappropriate use, and overuse of antibiotics is the primary driver of AMR, caused in part by clinicians relying on the use of broad-spectrum antibiotics, which increases​ resistance to ​last resort broad-spectrum antibiotics.

Resistant infections lead to higher death rates and are more expensive to treat.1

Antimicrobial Resistance and HealthTrackRx
Antimicrobial Resistance and HealthTrackRx

If our healthcare system fails to decrease AMR by 2050, deaths from antimicrobial resistant infections are estimated to total 10 million, more than cancer, diabetes, and road traffic accidents.2

PCR vs. Culture:

Patient Case Studies

HealthTrackRx PCR is the right solution for health plans that want to benefit from critical diagnostic testing factors to minimize AMR and costs associated with undetected infection.

Patient Case Study 1

Patient Case Study 2

Patient Case Study 3


Solutions for AMR

HealthTrackRx provides solutions that help decrease AMR through diagnostics that enable effective antibiotic stewardship practices.

Antimicrobial Resistance and HealthTrackRx

HealthTrackRx SOLUTION

Rapid Diagnostics

Rapid diagnostics would reduce unnecessary prescriptions.4

Antimicrobial Resistance and HealthTrackRx

HealthTrackRx PCR returns results within 24 hours, as compared to 3-14 days with culture, enabling rapid, more comprehensive diagnoses.

Operating in all 50 states, HeathTrackRx’s state-of-the-art ordering platform and logistics solutions guarantees practitioners clinically actionable results within 24 hours of receipt.

Antimicrobial Resistance and HealthTrackRx

HealthTrackRx SOLUTION

Personalized Antibiogram

Antimicrobial Resistance and HealthTrackRx

How it Works

Our patient-specific antibiogram offers physicians a wide selection of microbe-specific antibiotics, maximizing the opportunity to choose a non-broad-spectrum antibiotic. Our results detail targeted monotherapy for simple infections and allow for combination antibiotic treatment for complex infections to avoid broad spectrum antibiotic use and specialty antibiotics when possible.

With personalized AMR results, clinicians can prescribe with confidence, significantly reducing the costs of treatment, and improving patient health.

Antimicrobial Resistance and HealthTrackRx

HealthTrackRx SOLUTION

Advancing Antimicrobial Stewardship

Antimicrobial Resistance and HealthTrackRx

Utilizing HealthTrackRx PCR testing helps health plans manage spend and support population health management.

Clinically actionable prescribing information directly reduces the incidence of sepsis and other complications landing patients in the ER and limits reliance on specialty compound therapeutics.


Managed Care Coverage

HealthTrackRx contracts with Medicare, Medicaid, and most commercial payers for infectious disease testing. Hundreds of national and regional health plans already see the value in HealthTrackRx’s PCR-based testing.

Antimicrobial Resistance and HealthTrackRx
Take Action Now to Mitigate Risk and Reduce Unnecessary Expenditures
Antimicrobial resistance is recognized as one of the greatest threats to human health worldwide according to the IDSA.5

2 Filice GA, Nyman JA, Lexau C, Lees CH, Bockstedt LA, Como-Sabetti K, Lesher LJ, Lynfield R. Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection. Infect Control Hosp Epidemiol. 2010 Apr;31(4):365-73. doi: 10.1086/651094. PMID: 20184420. And Review on Antimicrobial Resistance.
3 and Review on Antimicrobial Resistance.
4 Shapiro DJ, Hicks LA, Pavia AT, Hersh AL. Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09. J Antimicrob Chemother. 2014 Jan;69(1):234-40. doi: 10.1093/jac/dkt301. Epub 2013 Jul 25. PMID: 23887867 and Review on Antimicrobial Resistance.
6Advances in Nutrition, Volume 8, Issue 1, January 2017, Pages 80-91